EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease

Stephanie Ioannou, Ashley Beecham, Lissette Gomez, Ryan Dauer, Nidah Khakoo, Lauren Pascual, Maria Quintero, Joanna Lopez, James S Leavitt, Norma Solis, Mailenys Ortega, Amar R Deshpande und 9 weitere

Clinical Gastroenterology and Hepatology · 2025

DOI: 10.1016/j.cgh.2024.07.032 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025. Verfasst von Stephanie Ioannou und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida. Hauptthemen laut MEDLINE: Hispanic or Latino, Inflammatory Bowel Diseases, Leukopenia, Pyrophosphatases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: The prevalence of inflammatory bowel disease among Hispanic/Latine communities is increasing. Pharmacogenomic studies reveal genetic markers that influence treatment decisions. The aim of our study was to examine the frequency and impact of genetic polymorphisms on thiopurine-associated leukopenia (NUDT15, TPMT) and anti-tumor necrosis factor (TNF) immunogenicity (HLA-DQA1∗05) in a cohort of Hispanic patients of diverse ancestral backgrounds. METHODS: We performed a multicenter, retrospective cohort study comprising 2225 Hispanic participants. We measured the frequency of variation affecting drug response in NUDT15, TPMT, and HLA-DQA1∗05; their ancestral origin (European, African, or Amerindian); and the rate of development of myelosuppression and immunogenicity to thiopurines and anti-TNFs, in exposed patients. RESULTS: NUDT15 and TPMT variants were rare, except for rs116855232 in NUDT15, which was common only in alleles of Amerindian origin. All NUDT15 variant alleles were inherited on an Amerindian haplotype, and among the Amerindian allele subset, the variant frequency of NUDT15∗4 (rs147390019) was a remarkable 23% in patients with leukopenia but only 3% in patients without leukopenia. HLA-DQA1∗05 and its European tagging variant rs2097432 were common in alleles from all ancestral origins and demonstrated association with immunogenicity to anti-TNFs. However, rs2097432 was only correlated with HLA-DQA1∗05 in the European allele subset. CONCLUSIONS: These findings indicate that NUDT15 testing should become standard clinical practice before prescribing thiopurines in individuals with Amerindian/Alaska Native ancestry, including Hispanic individuals. Additionally, rs2097432 should not be used as a surrogate for HLA-DQA1∗05 testing for diverse populations. Ultimately, incorporating ancestry in personalized therapeutic approaches is important for treatment of Hispanic patients with inflammatory bowel disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hispanic or LatinoInflammatory Bowel DiseasesLeukopeniaPyrophosphatasesAdultAgedFemaleHumansMaleMiddle AgedYoung AdultHLA-DQ alpha-ChainsMethyltransferasesPharmacogeneticsRetrospective StudiesWhiteIndians, South AmericanAlaska NativesNudix Hydrolases

Stichwörter der Autor:innen

Crohn’s DiseaseHispanic/LatineInflammatory Bowel DiseasePharmacogenomicsUlcerative Colitis

Substanzen

HLA-DQ alpha-ChainsHLA-DQA1 antigenMethyltransferasesNUDT15 protein, humanPyrophosphatasesTPMT protein, humanNudix Hydrolases

Autor:innen und Institutionen

  • Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida.
  • John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida.
  • Department of Gastroenterology, Gastro Health, Miami, Florida.
  • Department of Gastroenterology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico.
  • F. Widjaja Foundation Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: omazorra@med.miami.edu.

Förderung

  • NIDDK NIH HHS
  • NIDDK

Zitieren

APA

Ioannou, S., Beecham, A., Gomez, L., Dauer, R., Khakoo, N., Pascual, L., Quintero, M., Lopez, J., Leavitt, J. S., Solis, N., Ortega, M., Deshpande, A. R., Kerman, D. H., Proksell, S., Torres, E. A., Haritunians, T., Li, D., Abreu, M. T., McGovern, D. P. B., …, & Damas, O. M. (2025). Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.07.032

Vancouver

Ioannou S, Beecham A, Gomez L, Dauer R, Khakoo N, Pascual L, et al. Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 2025. doi:10.1016/j.cgh.2024.07.032

BibTeX
@article{Ioannou2025,
  author = {Ioannou, Stephanie and Beecham, Ashley and Gomez, Lissette and Dauer, Ryan and Khakoo, Nidah and Pascual, Lauren and Quintero, Maria and Lopez, Joanna and Leavitt, James S and Solis, Norma and Ortega, Mailenys and Deshpande, Amar R and Kerman, David H and Proksell, Siobhan and Torres, Esther A and Haritunians, Talin and Li, Dalin and Abreu, Maria T and McGovern, Dermott P B and McCauley, Jacob L and Damas, Oriana M},
  title = {Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1016/j.cgh.2024.07.032}
}
Kostenlos starten →